| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.001 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |